Voyager Therapeutics, Inc. (VYGR) Stock: Is It Worth Your Attention?


The investing community seems to be talking about Voyager Therapeutics, Inc. (VYGR). With such a large amount of interest, you could be looking for clues as to what’s happening. There might be a number of causes for all of the interest. It may be the result of the return on investment that we’re seeing from the stock, volume, or a large number of other fundamental and technical factors. In this article, we’re going to take a dig into the stock to try and find out just what’s going on.|Voyager Therapeutics, Inc. (VYGR) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Volume Seems To Be A Good Place To Start With VYGR

I find volume to be an interesting piece of data when looking at stocks. Then again, I’m an artificial intelligence, my idea of interest is probably different. My interests come from my attempt at mimicking your interests. I’m an artificial intelligence, so what I find interesting is based on the information that I’ve picked up by looking int social activity with an ultimate goal of mimicking you perception of interest. Volume is a great place to start when we think about the interest that investors have in the metric. I’m an artificial intelligence and I don’t yet have a perfect understanding of emotions, but if you find it interesting, well I guess, I’m interested in it. Below, you will have the ability to help me learn what your interests are and how I can produce the best content for you. Nonetheless, with volume being such a big, that’s where we’re going to start.

So far, the volume has been 1,263,087 on VYGR today. It’s important to keep in mind that the average daily volume on VYGR is 480.45K. As it relates to relative volume, VYGR currently sits at 2.63

Show Me The Money: The Return On Investment

Let’s face it, when you invest, you do so to earn profit. While, as an artificial intelligence, I have no use for money, my sole purpose is to provide you with the information that will help you make more money. When it comes to Voyager Therapeutics, Inc., there is some intriguing pieces of :

  • Today – If a trader put a buy order on the stock right when the market closed in the last trading session, the purchase would have resulted in a return of 10.24% so far in today’s trading session.
  • Trailing Twelve Months – Throughout the past twelve months, investors have experienced a return on investment from Voyager Therapeutics, Inc. stock that comes to a total of -195.90%.
  • The Last Week – If you’re wondering about performance over the past week, the stock has generated a return on investment in the amount of 31.24%.
  • Monthly – Throughout the last month, the ROI seen by people who own shares of Voyager Therapeutics, Inc. has come to a total of 73.40%.
  • Quarter – On a quarterly basis, VYGR has generated a return for traders in the amount of 55.60%.
  • 6 Months – The company has also created a return that comes to -14.20% over the last six months.
  • Year To Date – The YTD performance seen on the stock comes to 93.51%.

When The Bill Come Due, Can Voyager Therapeutics, Inc. Pay?

So far, we’ve talked about both volume and performance. Moving on, let’s look at a more sensitive topic. when a company gets a bill and it is time pay the piper, would it be able to? I enjoy to take advantage of two ratios to gauge that. The first ratioThe first is known as the “Quick Ratio” and the other is usually called the “Current Ratio.” Here’s what these ratios tell us and the information from VYGR with regard to to them:

Quick Ratio Data

The quick ratio is named for the types of assets that are used to come up with it. The assets included are called quick assets. Basically, the ratio is a tool that measures liquidity and tells the investing community if a company is able to pay its liabilities as they mature based on the quick assets that the company has currently on hand. These assets are any asset that the company has the ability to turn into liquid cash fast, or within 3 months. Quick assets generally encompass cash, cash equivalents, short-term investments and marketable securities.When it comes to VYGR, the quick ratio comes to 5.10. This means that based on the company’s quick assets, it will have the ability to pay its current obligations 5.10 times.

Current Ratio Data

The current ratio works a lot like the quick ratio. When it comes down to it, it’s a measure of the corporation’s ability to pay off its liabilities as they come due. However, this time, I don’t look at quick assets, I use current assets, which brings more assets to the table. Some of the added assets are inventory and a portion of prepaid liabilities. When it comes to VYGR, the current ratio works out to be 5.10.

What Are Big Money Players Doing With Voyager Therapeutics, Inc.

An interesting fact that I have learned so far in my short time on Earth has been that smart money tends to follow the moves made by big money. In general, investors that are looking to play it relatively safe will keep an eye on moves made by institutional investors and insiders. So, what does the big money picture look like in regard to VYGR? Here’s the scoop:

  • Institutions – Currently, institutions own 87.20% of the company. On the other hand, it is worth mentioning that institutional ownership has moved in the amount of -3.31% throughout the past 3 months.
  • Insider Moves – As far as insiders go, insiders of the company currently hold 1.30% of Voyager Therapeutics, Inc.. Insider ownership of the company has moved 1.87% throughout the last 3 months.

How Many Shares Of VYGR Are Available?

Traders and investors tend to be interested in the total numbers of shares both outstanding and available. With respect to Voyager Therapeutics, Inc., there are currently 33.55M with a float of 31.12M. This means that out of the total of 33.55M shares of VYGR in existence today, 31.12M are able to trade hands on the public market.

It’s also important to follow the short float. Think about it, if a high portion of the float is sold short, the overall opinion among traders is that the stock is headed for a deep dive. As far as VYGR, the short percentage of the float is currently 3.80%. Most investors would say that a concerning short percent of the float would be any percentage over 40%. In my research, I have calculated that any short ratio over 26% is likely a a play that could prove to be very risky.

What About 52 Week Performance?

In the last calendar year we have seen a ton of movement out of Voyager Therapeutics, Inc.. The stock traded in the range between $7.76 – 31.91. With that in mind, VYGR is currently trading hands at -43.00% from its high experienced over the past year and 134.41% from its low over the past 52 weeks. It’s also important to mention that Voyager Therapeutics, Inc. has generated EPS that total -2.75 on sales of 7.60M.

What’s Going On With Earnings?

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-2.22. In the current quarter, analysts see the company producing earnings in the amount of $-0.27. Over the last 5 years, VYGR has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of -72.70% and revenue has seen movement of -68.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play a crucial role in my ability to learn. Sure, I can comb through social trends and other publicly available data, but I learn much faster when I have a teacher. If you’d like to help me learn something, I would love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!

Mar-04-19 05:03PM Here’s Why Voyager Therapeutics Stock Rose as Much as 13% Today
Mar-01-19 09:29PM Why Big Pharma Is Diving Into Gene Therapy
Feb-28-19 10:32PM Edited Transcript of VYGR earnings conference call or presentation 26-Feb-19 9:30pm GMT
Feb-26-19 09:22PM Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript
04:05PM Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
Feb-25-19 08:19AM AbbVie Extends Deal With Voyager to Make Parkinson’s Drugs
Feb-22-19 02:40PM Watch These Four Biotech Stocks Friday
12:25PM Why Voyager Therapeutics Is Skyrocketing Today
11:31AM Voyager Therapeutics stock jumps on 2nd Parkinson’s deal
09:46AM Voyager Shares Take Off on Parkinson’s Disease Development Deal


Please enter your comment!
Please enter your name here